Arthritis of Hip Clinical Trial
Official title:
Better Before - Better After: Prehabilitation Program for Older Patients Awaiting Total Hip Replacement. A Randomised Controlled Trial
Verified date | November 2023 |
Source | Oslo Metropolitan University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Health professions need to prepare for the large increase in the number of older people with OA requiring health services including TJA surgery. Older age and poor physical function influences the postoperative prognosis of TJA. At discharge from hospital after TJA, studies have shown that gait speed can be severely impaired among older patients. The investigators hypothesize that an exercise program of 6-12 weeks will be beneficial for patients that are undergoing TJA.
Status | Active, not recruiting |
Enrollment | 103 |
Est. completion date | March 31, 2026 |
Est. primary completion date | May 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 70 Years and older |
Eligibility | Inclusion Criteria: - Participants 70 years or older living at home with residential address in the county of Oslo or Akershus scheduled for elective primary total hip replacement due to end-stage osteoarthritis. - Harris Hip Score >60. - Participants must also be capable in Norwegian and be able to follow exercise sessions. Exclusion Criteria: - Patients with known rheumatoid arthritis or medical contraindications or those who are scheduled for revision of hip arthroplasty - Unable to speak and understand the Norwegian language. - Patients with neurological disorders affecting gait - Medical contraindications for exercise |
Country | Name | City | State |
---|---|---|---|
Norway | OsloMet | Oslo |
Lead Sponsor | Collaborator |
---|---|
Oslo Metropolitan University |
Norway,
Bitton R. The economic burden of osteoarthritis. Am J Manag Care. 2009 Sep;15(8 Suppl):S230-5. — View Citation
Slatkowsky-Christensen B, Grotle M. Artrose i Norge. Norsk Epidemiologi 2008;18(1)
Wallace IJ, Worthington S, Felson DT, Jurmain RD, Wren KT, Maijanen H, Woods RJ, Lieberman DE. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):9332-9336. doi: 10.1073/pnas.1703856114. Epub 2017 Aug 14. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in gait speed | 40 meters Fast-Paced Walk test | Change measure: Baseline, within one week after intervention, 6 weeks after intervention, 3 months after intervention, 6 months after intervention and 12 months after intervention | |
Secondary | Change in physical function | 30 second sit-to stand test | Change measure: Baseline, within one week after intervention, 6 weeks after intervention, 3 months after intervention, 6 months after intervention and 12 months after intervention | |
Secondary | Change in aerobic capacity | 6 min walk test | 1 week before intervention, directly after intervention as well as 6 and 12 weeks after TJA-surgery | |
Secondary | Change in transitional ambulation | Timed-up and go Test (TUG) | Change measure: Baseline, within one week after intervention, 6 weeks after intervention, 3 months after intervention, 6 months after intervention and 12 months after intervention | |
Secondary | Change in pain measured with numeric rating scale (NRS) | NRS - Single score, low score indicates low pain, high score indicated high levels of pain | Change measure: Baseline, within one week after intervention, 6 weeks after intervention and 3 months after intervention | |
Secondary | Length of stay in hospital | Number of days | From date of hospital admission until the date of hospital discharge, assessed up to 12 months | |
Secondary | Change in the ability to climb stairs | Stair-climb test. Timed performance from start to stop | Change measure: Baseline, within one week after intervention, 6 weeks after intervention, 3 months after intervention, 6 months after intervention and 12 months after intervention | |
Secondary | Change in Health Status measured with EuroQol-5 dimensions (EQ-5D) | EQ-5D, five dimensions of health scored from 1-5, with 1 being no problem and 2-5 indicate increasing problem (higher score = increase in problem) | Change measure: Baseline, within one week after intervention, 6 weeks after intervention, 3 months after intervention, 6 months after intervention and 12 months after intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05065775 -
Bioavailability of Intranasal Dexmedetomidine
|
Phase 4 | |
Completed |
NCT03540667 -
Study of Hip and Knee Arthroplasty in South Africa
|
||
Completed |
NCT04441112 -
Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial
|
Phase 2/Phase 3 | |
Recruiting |
NCT05366712 -
Nexus Evaluation Primary Trident II Uncemented Shell
|
N/A | |
Completed |
NCT03375112 -
Fascia Iliaca Blocks for Pain Control After Total Hip Arthroplasty
|
Phase 4 | |
Not yet recruiting |
NCT05736016 -
Medial Wedge Insoles to Improve Gait in Persons After Total Hip Replacement
|
N/A | |
Recruiting |
NCT05957822 -
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
|
Phase 4 | |
Not yet recruiting |
NCT05956769 -
Goal-directed vs Preemptive Tranexamic Acid Administration in Total Hip Arthroplasty
|
N/A | |
Completed |
NCT03069183 -
Ultrasound-guided Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Total Hip Arthroplasty
|
Phase 2/Phase 3 | |
Enrolling by invitation |
NCT04928924 -
Immediate Post-THA Functional Assessment
|